Organ damage risk for lupus patients
In findings from a new global survey, nearly half (44 per cent) of the expert healthcare professionals (HCPs) surveyed across seven ...
Read moreIn findings from a new global survey, nearly half (44 per cent) of the expert healthcare professionals (HCPs) surveyed across seven ...
Read moreBioNTech SE (BioNTech) announced on Dec 23, 2022, the initiation of a first-in-human Phase 1 study with BNT165b1, the first candidate ...
Read moreModerna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and OriCiro Genomics K.K., a pioneer in cell-free DNA ...
Read moreRevon Media Sdn Bhd
A-5-1, Block A, Parklane Commercial Hub,
Jalan SS 7/26, SS7, 47301 Petaling Jaya,
Selangor Darul Ehsan, Malaysia.
Tel: +603 7886 6091
Fax: +6 03 3358 0303
Copyright © 2021 Revon Media Sdn Bhd. A publication of Revon Media Sdn Bhd. About Us | Contact Us | Privacy Policy | Terms of use